{"id":"https://openalex.org/W2801646377","doi":"https://doi.org/10.1016/j.sapharm.2018.03.059","title":"Capturing enhanced MTM services through development of encounter data and quality indicator measures","display_name":"Capturing enhanced MTM services through development of encounter data and quality indicator measures","publication_year":2018,"publication_date":"2018-05-01","ids":{"openalex":"https://openalex.org/W2801646377","doi":"https://doi.org/10.1016/j.sapharm.2018.03.059","mag":"2801646377"},"language":"en","primary_location":{"id":"doi:10.1016/j.sapharm.2018.03.059","doi":"https://doi.org/10.1016/j.sapharm.2018.03.059","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.sapharm.2018.03.059","pdf_url":null,"source":{"id":"https://openalex.org/S50431791","display_name":"Research in Social and Administrative Pharmacy","issn_l":"1551-7411","issn":["1551-7411","1934-8150"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research in Social and Administrative Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113862423","display_name":"Christine Gill","orcid":"https://orcid.org/0009-0005-8236-4653","observed_orcids":["https://orcid.org/0009-0005-8236-4653"]},"institutions":[{"id":"https://openalex.org/I4210155539","display_name":"Impaq International (United States)","ror":"https://ror.org/04kb0nk47","country_code":"US","type":"company","lineage":["https://openalex.org/I1293631320","https://openalex.org/I4210155539"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christine Gill","raw_affiliation_strings":["IMPAQ International, LLC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPAQ International, LLC, USA","institution_ids":["https://openalex.org/I4210155539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020951666","display_name":"Corey Triebwasser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155539","display_name":"Impaq International (United States)","ror":"https://ror.org/04kb0nk47","country_code":"US","type":"company","lineage":["https://openalex.org/I1293631320","https://openalex.org/I4210155539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey Triebwasser","raw_affiliation_strings":["IMPAQ International, LLC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPAQ International, LLC, USA","institution_ids":["https://openalex.org/I4210155539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076630146","display_name":"Evan Perlman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155539","display_name":"Impaq International (United States)","ror":"https://ror.org/04kb0nk47","country_code":"US","type":"company","lineage":["https://openalex.org/I1293631320","https://openalex.org/I4210155539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Perlman","raw_affiliation_strings":["IMPAQ International, LLC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPAQ International, LLC, USA","institution_ids":["https://openalex.org/I4210155539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103158353","display_name":"Lanlan Xu","orcid":"https://orcid.org/0000-0002-5527-2906","observed_orcids":["https://orcid.org/0000-0002-5527-2906"]},"institutions":[{"id":"https://openalex.org/I4210155539","display_name":"Impaq International (United States)","ror":"https://ror.org/04kb0nk47","country_code":"US","type":"company","lineage":["https://openalex.org/I1293631320","https://openalex.org/I4210155539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lanlan Xu","raw_affiliation_strings":["IMPAQ International, LLC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPAQ International, LLC, USA","institution_ids":["https://openalex.org/I4210155539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035035901","display_name":"Zippora Kiptanui","orcid":"https://orcid.org/0000-0003-1212-7642","observed_orcids":["https://orcid.org/0000-0003-1212-7642"]},"institutions":[{"id":"https://openalex.org/I4210155539","display_name":"Impaq International (United States)","ror":"https://ror.org/04kb0nk47","country_code":"US","type":"company","lineage":["https://openalex.org/I1293631320","https://openalex.org/I4210155539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zippora Kiptanui","raw_affiliation_strings":["IMPAQ International, LLC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPAQ International, LLC, USA","institution_ids":["https://openalex.org/I4210155539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112344640","display_name":"Karin E. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155539","display_name":"Impaq International (United States)","ror":"https://ror.org/04kb0nk47","country_code":"US","type":"company","lineage":["https://openalex.org/I1293631320","https://openalex.org/I4210155539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karin Johnson","raw_affiliation_strings":["IMPAQ International, LLC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPAQ International, LLC, USA","institution_ids":["https://openalex.org/I4210155539"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000066395","display_name":"Ilene Harris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155539","display_name":"Impaq International (United States)","ror":"https://ror.org/04kb0nk47","country_code":"US","type":"company","lineage":["https://openalex.org/I1293631320","https://openalex.org/I4210155539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ilene Harris","raw_affiliation_strings":["IMPAQ International, LLC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPAQ International, LLC, USA","institution_ids":["https://openalex.org/I4210155539"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113862423"],"corresponding_institution_ids":["https://openalex.org/I4210155539"],"apc_list":{"value":4880,"currency":"USD","value_usd":4880},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05703847,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"5","first_page":"e15","last_page":"e15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.04349999874830246,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12871","display_name":"Healthcare Quality and Management","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/3605","display_name":"Health Information Management"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medication-therapy-management","display_name":"medication therapy management","score":0.8109999895095825},{"id":"https://openalex.org/keywords/quality-indicators","display_name":"quality indicators","score":0.949999988079071},{"id":"https://openalex.org/keywords/pharmaceutical-care","display_name":"pharmaceutical care","score":0.6230000257492065},{"id":"https://openalex.org/keywords/data-collection","display_name":"data collection","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.528638482093811},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.43812233209609985},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.32433152198791504},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.sapharm.2018.03.059","doi":"https://doi.org/10.1016/j.sapharm.2018.03.059","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.sapharm.2018.03.059","pdf_url":null,"source":{"id":"https://openalex.org/S50431791","display_name":"Research in Social and Administrative Pharmacy","issn_l":"1551-7411","issn":["1551-7411","1934-8150"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research in Social and Administrative Pharmacy","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7246000170707703}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2390826888","https://openalex.org/W2896571149","https://openalex.org/W4390721086","https://openalex.org/W2799993523","https://openalex.org/W7217599785","https://openalex.org/W894499666","https://openalex.org/W4413887629","https://openalex.org/W7049116977","https://openalex.org/W4245617500","https://openalex.org/W3022971444"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2018-05-17T00:00:00"}